(SKWD) Skyward Specialty Insurance - Overview
Sector: Financial Services | Industry: Insurance - Property & Casualty | Exchange: NASDAQ (USA) | Market Cap: 1.918m USD | Total Return: -7.5% in 12m
Liability, Property, Auto, Workers Comp, Specialty
Total Rating 27
Safety 45
Buy Signal -0.49
Insurance - Property & Casualty
Industry Rotation: -6.1
Industry Rotation: -6.1
Market Cap:
1.92B
Avg Turnover: 17.6M USD
Avg Turnover: 17.6M USD
ATR:
3.58%
Peers RS (IBD): 22.3
Peers RS (IBD): 22.3
Risk 5d forecast
Volatility34.4%
Rel. Tail Risk-1.87%
Reward TTM
Sharpe Ratio-0.54
Alpha-30.17
Character TTM
Beta0.521
Beta Downside1.005
Drawdowns 3y
Max DD36.52%
CAGR/Max DD0.79
EPS (Earnings per Share)
EPS CAGR: -39.02%
EPS Trend: 40.1%
EPS Trend: 40.1%
Last SUE: -4.00
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: 30.17%
Rev. Trend: 98.3%
Rev. Trend: 98.3%
Last SUE: 0.11
Qual. Beats: 0
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: SKWD Skyward Specialty Insurance
Skyward Specialty Insurance Group, Inc. (SKWD) is a U.S.-based insurance holding company. It underwrites commercial property and casualty insurance.
The company offers a diverse portfolio of insurance products. These include general liability, excess liability, professional liability, and commercial auto insurance. It also provides specialized coverage such as cannabis insurance, a niche within the broader insurance market.
SKWD operates in the Property & Casualty Insurance sector, a segment of the financial industry focused on protecting businesses and individuals from financial losses due to property damage, liability claims, and other covered perils. The company was incorporated in 2006 and is headquartered in Houston, Texas.
For more in-depth data and analytics, explore ValueRay.
- Commercial property insurance demand impacts premium growth
- Catastrophic weather events increase claims payouts
- Interest rate changes affect investment income
- Regulatory changes influence underwriting profitability
- Competition in specialty insurance markets pressures pricing
Piotroski VR‑10 (Strict)
6.0
| Net Income: 170.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.33 > 1.0 |
| NWC/Revenue: -77.04% < 20% (prev 188.2%; Δ -265.2% < -1%) |
| CFO/TA 0.09 > 3% & CFO 408.1m > Net Income 170.0m |
| Net Debt (-1.90b) to EBITDA (223.6m): -8.52 < 3 |
| Current Ratio: 0.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.9m) vs 12m ago 0.60% < -2% |
| Gross Margin: 48.44% > 18% (prev 0.29%; Δ 4.82k% > 0.5%) |
| Asset Turnover: 33.31% > 50% (prev 30.77%; Δ 2.53% > 0%) |
| Interest Coverage Ratio: 28.33 > 6 (EBITDA TTM 223.6m / Interest Expense TTM 7.92m) |
Altman Z''
-0.88
| A: -0.23 (Total Current Assets 2.57b - Total Current Liabilities 3.66b) / Total Assets 4.79b |
| B: 0.06 (Retained Earnings 267.1m / Total Assets 4.79b) |
| C: 0.05 (EBIT TTM 224.3m / Avg Total Assets 4.26b) |
| D: 0.07 (Book Value of Equity 279.0m / Total Liabilities 3.78b) |
| Altman-Z'' Score: -0.88 = CCC |
Beneish M
-3.51
| DSRI: 0.37 (Receivables 544.2m/1.18b, Revenue 1.42b/1.15b) |
| GMI: 0.59 (GM 48.44% / 28.57%) |
| AQI: 1.49 (AQ_t 0.46 / AQ_t-1 0.31) |
| SGI: 1.24 (Revenue 1.42b / 1.15b) |
| TATA: -0.05 (NI 170.0m - CFO 408.1m) / TA 4.79b) |
| Beneish M-Score: -3.51 (Cap -4..+1) = AAA |
What is the price of SKWD shares?
As of April 07, 2026, the stock is trading at USD 43.93 with a total of 285,100 shares traded.
Over the past week, the price has changed by +1.49%, over one month by -8.89%, over three months by -6.43% and over the past year by -7.50%.
Over the past week, the price has changed by +1.49%, over one month by -8.89%, over three months by -6.43% and over the past year by -7.50%.
Is SKWD a buy, sell or hold?
Skyward Specialty Insurance has received a consensus analysts rating of 3.83.
Therefore, it is recommended to buy SKWD.
- StrongBuy: 3
- Buy: 4
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SKWD price?
| Analysts Target Price | 61.5 | 39.9% |
Skyward Specialty Insurance (SKWD) - Fundamental Data Overview
as of 03 April 2026
P/E Trailing = 10.5823 P/E Forward = 8.8417
P/S = 1.3543
P/B = 1.9272
P/EG = 0.7245
Revenue TTM = 1.42b USD
EBIT TTM = 224.3m USD
EBITDA TTM = 223.6m USD
Long Term Debt = 120.0m USD (from longTermDebt, last quarter)
Short Term Debt = 43.0m USD (from shortTermDebt, two quarters ago)
Debt = 120.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.90b USD (recalculated: Debt 120.0m - CCE 2.02b)
Enterprise Value = 13.6m USD (1.92b + Debt 120.0m - CCE 2.02b)
Interest Coverage Ratio = 28.33 (Ebit TTM 224.3m / Interest Expense TTM 7.92m)
EV/FCF = 0.03x (Enterprise Value 13.6m / FCF TTM 402.6m)
FCF Yield = 2.96k% (FCF TTM 402.6m / Enterprise Value 13.6m)
FCF Margin = 28.37% (FCF TTM 402.6m / Revenue TTM 1.42b)
Net Margin = 11.98% (Net Income TTM 170.0m / Revenue TTM 1.42b)
Gross Margin = 48.44% ((Revenue TTM 1.42b - Cost of Revenue TTM 731.7m) / Revenue TTM)
Gross Margin QoQ = none% (prev 31.18%)
Tobins Q-Ratio = 0.00 (Enterprise Value 13.6m / Total Assets 4.79b)
Interest Expense / Debt = 1.91% (Interest Expense 2.29m / Debt 120.0m)
Taxrate = 20.89% (11.4m / 54.6m)
NOPAT = 177.5m (EBIT 224.3m * (1 - 20.89%))
Current Ratio = 0.70 (Total Current Assets 2.57b / Total Current Liabilities 3.66b)
Debt / Equity = 0.12 (Debt 120.0m / totalStockholderEquity, last quarter 1.01b)
Debt / EBITDA = -8.52 (Net Debt -1.90b / EBITDA 223.6m)
Debt / FCF = -4.73 (Net Debt -1.90b / FCF TTM 402.6m)
Total Stockholder Equity = 930.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.99% (Net Income 170.0m / Total Assets 4.79b)
RoE = 18.27% (Net Income TTM 170.0m / Total Stockholder Equity 930.4m)
RoCE = 21.36% (EBIT 224.3m / Capital Employed (Equity 930.4m + L.T.Debt 120.0m))
RoIC = 16.90% (NOPAT 177.5m / Invested Capital 1.05b)
WACC = 7.44% (E(1.92b)/V(2.04b) * Re(7.81%) + D(120.0m)/V(2.04b) * Rd(1.91%) * (1-Tc(0.21)))
Discount Rate = 7.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 2.85%
[DCF] Terminal Value 83.44% ; FCFF base≈361.9m ; Y1≈446.5m ; Y5≈761.8m
[DCF] Fair Price = 374.9 (EV 14.80b - Net Debt -1.90b = Equity 16.70b / Shares 44.5m; r=7.44% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 40.10 | EPS CAGR: -39.02% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.34 | Revenue CAGR: 30.17% | SUE: 0.11 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.22 | Chg7d=-0.007 | Chg30d=+0.027 | Revisions Net=+0 | Analysts=10
EPS current Year (2026-12-31): EPS=4.88 | Chg7d=+0.010 | Chg30d=+0.072 | Revisions Net=+3 | Growth EPS=+22.1% | Growth Revenue=+27.7%
EPS next Year (2027-12-31): EPS=5.47 | Chg7d=-0.005 | Chg30d=+0.023 | Revisions Net=-1 | Growth EPS=+12.0% | Growth Revenue=+11.9%
[Analyst] Revisions Ratio: +0.60 (4 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -1.5% (Discount Rate 7.9% - Earnings Yield 9.4%)
[Growth] Growth Spread = +38.5% (Analyst 36.9% - Implied -1.5%)
External Resources